Clinical Laboratory

Agendia Inc. is a molecular diagnostics company specializing in genomic testing for early-stage breast cancer. The company develops and provides MammaPrint and BluePrint, two FDA-cleared genomic profiling tests that analyze tumor biology to assess recurrence risk and determine molecular subtype. MammaPrint is a 70-gene recurrence risk assay for HR+/HER2− early-stage breast cancer patients, while BluePrint is a molecular subtyping test that identifies the underlying genomic drivers of tumor growth. Results are delivered within 6 business days from a single tissue sample. These tests enable oncologists to personalize treatment decisions and reduce both under- and over-treatment. Agendia's assays are validated by multiple landmark clinical studies and recognized by major treatment guidelines including NCCN (National Comprehensive Cancer Network). The company serves leading physicians and institutions globally and maintains CLIA, CAP, and ISO certifications for laboratory operations. Agendia operates a CLIA-certified laboratory and provides test ordering through multiple physician portals. The company markets its services to oncology practices, cancer centers, and health systems in the Americas, Europe, and internationally.

Sakura Global Holding Company is a leading supplier of histopathology laboratory equipment and consumables for tissue processing, staining, imaging, and specimen tracking. The company operates a comprehensive workflow system spanning from tissue grossing and trimming through embedding, microtomy, primary and advanced staining (H&E, IHC, CISH, IF), coverslipping, digital slide imaging, and specimen storage. Key product lines include the Tissue-Tek brand for staining and tissue processing, the NanoZoomer S540 Digital Slide Scanner for whole-slide digitization (research use), KUBTEC specimen imaging systems, the Tissue-Tek X-CHEQ C automated cassette tracking system for barcode-based specimen management, and the Tissue-Tek Genie Advanced Staining System for flexible immunohistochemistry workflows. The company serves clinical diagnostic laboratories, research institutions, and dermatopathology practices. Products are designed to reduce variability across the histology workflow and improve stain quality and consistency. Sakura serves the North American market with FDA-regulated diagnostic equipment and research-grade instruments. The company demonstrates strong market presence in clinical dermatopathology and general anatomic pathology.

MilliporeSigma is a global life sciences supplier offering laboratory chemicals, consumables, equipment, and services for research, biomanufacturing, and analytical testing. The company operates under multiple brand portfolios: Sigma-Aldrich provides research chemicals, solvents, reagents, reference materials, and labware; Millipore specializes in filtration products, membrane technologies, and biopharmaceutical manufacturing solutions; SAFC supplies pharmaceutical and biopharmaceutical raw materials; Supelco offers analytical chromatography products and standards; Milli-Q provides laboratory water purification systems and consumables; and BioReliance delivers contract testing and quality assurance services. Product lines include certified reference materials, microbial culture media, syringe filters, centrifugal devices (Amicon), filter membranes, pipette tips, glassware, cell separation media, water purification cartridges, and bioprocessing platforms. MilliporeSigma serves pharmaceutical development, biomanufacturing, clinical diagnostics, food and beverage testing, and academic research markets. The company emphasizes sustainability initiatives, offering greener alternative products and returnable solvent systems (ReCycler). Services include consultative workflow optimization and contract manufacturing support. Operations span multiple locations with comprehensive global distribution and customer support infrastructure.

LifeSign LLC is a medical diagnostic company specializing in high-quality rapid point-of-care (POC) testing solutions for the healthcare industry. The company manufactures and distributes a comprehensive portfolio of diagnostic test kits and reagents across multiple clinical specialties, including infectious disease, women's health, cardiac care, urology, gastrointestinal health, drugs of abuse screening, hygiene, and industrial applications. Key product lines include the Status™ rapid test platform, covering COVID-19/Flu A&B multiplex testing, influenza B, mononucleosis, and strep A detection. LifeSign serves hospitals, clinics, urgent care centers, and other healthcare facilities requiring rapid, reliable diagnostic results at the point of care. The company emphasizes early detection and rapid diagnosis to improve clinical outcomes. LifeSign maintains manufacturing and quality systems appropriate for medical device distribution, with products distributed through a national sales and support network. The organization is positioned as a B2B supplier of diagnostic consumables and testing solutions for various medical markets.

Viant Medical is a vertically integrated contract manufacturing partner specializing in medical device design, development, and full-scale production. The company operates 25 global locations with 2.3 million square feet of factory space, including 299,000+ square feet of ISO-certified clean room capacity. Viant serves OEMs across multiple clinical markets: orthopedics (instruments, implants, delivery systems, UHMWPE components), surgical technologies (minimally invasive surgery, robotics, endoscopy, ophthalmology, wound care, biopsy, aesthetic surgery), cardiac and interventional devices (overmolding, nitinol tubing, hypotube precision components), drug delivery (auto-injectors, IV sets, connectors, respiratory devices), bioprocessing (containment, transfer, filtration systems), bioelectronics (pain management, sleep apnea, wearables), diagnostics and laboratory products (injection tubes, chromatography tubing), and respiratory/monitoring/patient care (masks, trach tubes, airway tubes, console components). Core manufacturing capabilities include precision metals and metal tubing, medical-grade plastics and silicone molding, extrusions, tooling, automation, device assembly, and finished device services. The company provides end-to-end solutions from prototyping through sterilization and packaging management. Viant emphasizes vertical integration to ensure quality control, reduce supply chain risk, and accelerate time-to-market. The ViaLaunch™ program offers program management support. The company focuses exclusively on medical device manufacturing and maintains operational expertise in complex assembly, overmolding, and materials science.

YSI Incorporated is a manufacturer of water quality monitoring and laboratory analytical instruments headquartered in Yellow Springs, Ohio. The company designs and produces a comprehensive portfolio of portable handheld meters, multiparameter sondes, benchtop laboratory analyzers, autonomous monitoring systems, and data management platforms for environmental water quality assessment and process control applications. Primary product lines include the EXO sonde series for long-term unattended water monitoring, Pro Series portable handhelds (ProDSS, ProQuatro, ProSolo) for field sampling, MultiLab benchtop multiparameter instruments with wireless capabilities, and IQ SensorNet online monitoring systems. YSI also manufactures specialized instruments such as the 9200 Total Organic Carbon Analyzer, ColorVis optical spectrophotometer, THM 1000 VOC analyzer, and autonomous platforms including the SurfBee surface vehicle and EcoMapper Nano underwater vehicle. The company offers integrated solutions through the HydroRIG remote data logger and HydroSphere cloud-based data visualization platform. Markets served include environmental consulting, wastewater treatment, drinking water utilities, aquaculture, research institutions, and industrial process monitoring. YSI provides expert consultation services, on-demand training programs (EXO University), and product selection tools to assist customers in instrument choice and application design. The company is part of Xylem, a global water technology leader.

Medical Electronic Systems (MES) is a global leader in semen analysis and sperm quality testing solutions. The company manufactures automated Sperm Quality Analyzers (SQA), laboratory validation kits, and consumer-direct fertility testing products. MES serves fertility clinics, reference laboratories, clinical laboratories, mail-in diagnostic programs, and at-home testing markets across the United States and internationally. The product portfolio includes the SQA-Vision and SQA-iOw automated analyzers for clinical laboratory use; QwikCheck validation and SQA supply kits for quality control and calibration; the YO Home Sperm Test for direct-to-consumer at-home semen analysis; and MaleMan lab services for comprehensive semen evaluation. All analyzers are CE-marked and FDA-cleared. The company maintains direct customer support, calibration and validation services, and international distribution capabilities. MES systems are deployed across fertility centers, major health systems (Kaiser Permanente, Sutter Health, UCHealth, NYC Health + Hospitals), reference laboratories (Labcorp, Quest Diagnostics), military installations (US Air Force, US Navy, US Army), and international institutions in France, Germany, Belgium, Canada, and Australia. The company emphasizes reliability, ease of use, reduced turnaround time, standardized reporting, and decreased manual labor requirements for clinical semen analysis workflows.

Chungdo Pharm. Co., Ltd. is a South Korean in-vitro diagnostic (IVD) medical device manufacturer specializing in urine test strips and diagnostic analyzers. The company develops and manufactures a comprehensive portfolio of diagnostic test strips for human and veterinary use, including Self-Stik series urine strips for diabetes, kidney function, liver health, urinary tract infection, calcium, vitamin C, nitric oxide, and oxidative stress monitoring. For veterinary applications, the company offers Self-Stik VET series strips customized for seven animal species (dogs, cats, cattle, horses, goats, sheep, pigs), as well as specialized veterinary products including kidney care, sugar care, liver care, and stone care monitoring strips. The company also manufactures AnyScan urine analyzers (CK-60, AnyScan 300, AnyScan 720) with varying throughput capacities (60–720 samples per hour), featuring PC data integration and patient management system compatibility. Additional products include control solutions (CK-Trol), Yocheck smartphone-connected veterinary urine analyzers, and emerging product lines for sodium monitoring and home diagnostic tools. Chungdo Pharm exhibits globally at major trade shows (KIMES, MEDLAB, AACC) and conducts R&D in drug/alcohol testing, lactate, uric acid, and nicotine detection. The company maintains FDA regulatory engagement and ISO compliance standards typical of IVD manufacturers serving clinical laboratories, hospitals, veterinary clinics, and home-use consumers.

PTW Freiburg is a family-owned global leader in dosimetry solutions for radiation medicine, with over a century of expertise. The company specializes in four core markets: radiation therapy, diagnostic radiology, metrology, and radiation monitoring. PTW develops and manufactures automated water phantoms (BEAMSCAN family), web-based quality assurance platforms (UNICHECK), modular patient QA systems (VERIQA), and AI contouring quality monitoring software (AIQUALIS). The company operates three manufacturing sites with 90% in-house development and production capability, employs approximately 450 staff worldwide, and maintains 12 international branch offices serving radiation experts across more than 160 countries. PTW operates one of the largest independent dosimetry calibration laboratories globally, performing over 12,000 calibrations annually in ionizing radiation. The company also provides comprehensive training through the PTW Dosimetry School, offering physical and virtual seminars, workshops, and webinars in multiple languages. Regulatory credentials and certifications are not explicitly detailed in available content, though the company emphasizes commitment to quality and sustainability, achieving EcoVadis Silver Medal recognition (top 10% sustainability rating). Manufacturing capability includes water phantom systems, software platforms for treatment planning QA, and calibration services.

Applied BioCode is an in-vitro diagnostics (IVD) manufacturer specializing in cost-effective, high-throughput syndromic panel testing for infectious diseases. The company designs and commercializes multiplex molecular diagnostic systems and assays that enable clinical and research laboratories to detect multiple pathogens simultaneously. The flagship BioCode® MDx-3000 platform processes up to 188 patient samples per 8-hour shift using 96-well format automation and can run up to three different syndromic panels in parallel. Core technology includes barcoded magnetic beads for multiplex PCR amplification, hybridization, target capture, and detection. Products address respiratory infections, gastrointestinal pathogens, SARS-CoV-2, sexually transmitted infections, and fungal pathogens. The platform offers data-masking capabilities to optimize insurance reimbursement and streamline laboratory workflows by eliminating the need for multiple instruments.

EPTAM Precision Solutions is a high-precision contract manufacturer specializing in close-tolerance machined and injection-molded components for mission-critical medical, aerospace & defense, and semiconductor applications. Founded in 1981 and headquartered in Northfield, New Hampshire, EPTAM serves the medical device industry with expertise in producing components for orthopedic implants, interventional cardiology devices, minimally invasive surgical instruments, and surgical robotics platforms. The company offers comprehensive capabilities including precision plastic injection molding, liquid silicone rubber (LSR) molding, metals machining, micro-machining, laser cutting and welding, and additive manufacturing. EPTAM provides integrated design-for-manufacturing (DFM) consultation, tooling development, production scaling, and quality assurance aligned with medical device regulatory standards. The company operates dedicated rapid prototyping facilities (READI) for fast-turn development and maintains approximately 152–500 employees. EPTAM partners with leading OEMs in biotech diagnostics, biopharma manufacturing, medical robotics, and implant sectors to accelerate time-to-market and ensure consistent product quality.

Maveric Medical is a medical device sales, marketing, and manufacturing company specializing in laboratory, acute care, and post-acute care solutions. Since 2015, the company has built a reputation for bringing innovative technologies to market through strong relationships across the healthcare industry and deep understanding of medical distribution channels. Their product portfolio focuses on blood collection and leukocyte reduction systems, serving hospitals and healthcare facilities with high-quality, competitively positioned medical devices. The company leverages over 20 years of combined experience in medical distribution and manufacturing, enabling rapid market entry and reliable product performance.

Eckert & Ziegler SE is a leading global provider of isotope technology for medical, scientific, and industrial applications. Headquartered in Berlin and listed on the Frankfurt Stock Exchange (TecDAX), the company specializes in cancer therapy, nuclear-medical imaging, and industrial radiometry. With approximately 1,143 employees, Eckert & Ziegler manufactures pharmaceutical-grade radioactive ingredients for cancer treatment and diagnosis. The company's core competencies include radiopharmaceutical synthesis, brachytherapy sources, hot cell solutions, and radiosynthesis technology. Its medical products segment delivers radioactive compounds for oncology and diagnostic imaging, while the isotope products segment manufactures radiation sources for medical and industrial applications. Eckert & Ziegler also develops quality control instruments and theranostic solutions, including specialized products such as Lutetium-177. The company has achieved significant market presence across Europe and North America through strategic acquisitions and partnerships.

CNMC Company is a specialized supplier of radiation physics and quality assurance equipment serving the medical radiation community. The company provides a comprehensive portfolio of dosimetry devices, ionization chambers, survey meters, brachytherapy accessories, phantoms, and calibration services. CNMC specializes in products for linear accelerator QA/QC, diagnostic radiology, brachytherapy localization, IMRT planning, and radiation protection. The product range includes electrometers, diode and MOSFET dosimeters, TLD dosimeters, ion chamber survey meters, personal dosimeters, various ionization chamber types, positioning and immobilization devices, and custom QA phantoms. The company also offers repair services and unparalleled customer support with custom product development capabilities.

Biomed Resource, Inc. is a FDA-registered manufacturer and wholesaler specializing in medical and laboratory consumables, hospital disposables, and clean room supplies for the U.S. biotechnology and healthcare industries. Operating with factory facilities overseas and warehouse headquarters in Riverside, California, the company provides a comprehensive range of plastic wares, specimen collection kits, viral collection systems, and related laboratory consumables. The company emphasizes quality assurance through integrated supply chain management—from design and manufacturing through consolidation and logistics—with design teams in both the U.S. and China. Biomed Resource offers full product customization across more than twenty healthcare and scientific categories, with a commitment to cost-effective pricing and responsive customer service.

Abingdon Health plc is a UK-based public limited company specializing in contract research, development, and manufacturing of lateral flow assay diagnostic tests. Headquartered at York Biotech Campus with operations in Doncaster, UK and Madison, Wisconsin, the company serves global clients across healthcare, animal health, and plant health sectors. Abingdon Health offers comprehensive lateral flow services from concept to commercial launch, including contract LFT development, scale-up and technical transfer, contract manufacturing, regulatory consultancy, quality assurance, analytical testing, and commercial support. The company provides flexible manufacturing solutions encompassing reagent preparation, spraying, lamination, kitting, assembly, and final batch release. Notable products include SaliStick, the world's first saliva-based pregnancy test, and the Simply Test range of self-tests. With expertise in biomarker validation, FDA PMA submissions, IVD and companion diagnostic development, Abingdon Health supports clients through complex regulatory pathways and large-scale manufacturing operations.

NEST Scientific is a worldwide manufacturer and distributor of high-quality plastic laboratory consumables and cell culture vessels, serving research institutions, clinical laboratories, and industrial biotech facilities across North America, Europe, Asia, and beyond. Founded in 2009 with manufacturing operations in Wuxi, China and distribution from Woodbridge, New Jersey, NEST maintains ISO 9001:2008, ISO 13485, CE, and FDA registration certifications. The company operates a high-precision manufacturing facility featuring ISO 8 grade cleanrooms, state-of-the-art injection molding equipment, and in-house E-Beam sterilization capabilities. NEST offers over 200 sterile and non-sterile plastic products including cell culture flasks and plates, centrifuge tubes, PCR plates, pipette tips, cryogenic vials, serological pipettes, and nasal drug delivery devices. Products serve molecular biology, immunoassay, liquid handling, qPCR/PCR, and bioprocessing applications.

Gene by Gene is a Houston-based CLIA-certified, CAP-accredited, and COLA-accredited clinical laboratory specializing in advanced genetic testing services. Founded in 2000, the company operates as a subsidiary of myDNA Inc. and provides a comprehensive spectrum of laboratory services including whole genome sequencing (WGS), whole exome sequencing (WES), custom targeted NGS panels, SNP array analysis, Sanger sequencing, and pharmacogenomics testing. The company serves clinical practitioners, researchers, and healthcare organizations globally with rapid turnaround times and competitive pricing. Gene by Gene's in-house laboratory features robotic automation and scalable sequencing and microarray technologies. Services extend to forensic genetics (through partnership with Verogen Inc.), paternity and relationship testing, population genetics research, and biobanking. The laboratory holds permits from multiple states including California, New York, Pennsylvania, and Maryland, and is AABB-accredited for relationship testing, ensuring exceptional result accuracy and compliance with regulatory standards.

Sebia Autoimmune & Infectious Diseases (formerly ZEUS Scientific) is a US-based in vitro diagnostic (IVD) company with 45+ years of clinical diagnostics expertise. Founded in 1976 and acquired by Sebia in October 2022, the company develops, manufactures, and markets high-quality immunoassays for autoimmune disorders and infectious diseases. ZEUS Scientific offers a portfolio of over 125 FDA-cleared assays utilizing Indirect Fluorescent Antibody (IFA) and Enzyme Immunoassay (EIA) technologies. Key products include automated IFA slide processing systems and digital immunofluorescence imaging solutions. The company provides comprehensive contract manufacturing, OEM partnerships, and custom diagnostic solutions. With deep expertise in immunofluorescence imaging, flow cytometry, and clinical protein electrophoresis, ZEUS Scientific supports hospital laboratories, clinical research organizations, and diagnostic manufacturers globally with workflow automation and quality assurance.

CliniSys is a global leader in laboratory informatics with over 40 years of experience, serving approximately 7,000 laboratory organizations worldwide across healthcare, biotech, pharmaceutical, contract services, environmental, and public health sectors. The company specializes in configurable SaaS-based Laboratory Information Management Systems (LIMS) and Laboratory Information Systems (LIS) platforms that enable digital transformation, workflow customization, and regulatory compliance. CliniSys solutions support clinical diagnostics, microbiology, genetics, immunology, pathology, and molecular biology disciplines. Key offerings include the Clinisys Laboratory Solution™, WinPath Enterprise LIMS, Horizon LIMS, ApolloLIMS, and ICE Order Comms Software, with specialized modules for genetics, immunogenetics, and disease surveillance. The platform integrates laboratory data across diverse sources, enhancing operational efficiency, data analytics, and decision-making for diagnostic and testing services at scale.

Moor Instruments is a global leader in designing, manufacturing, and distributing innovative systems for non-invasive tissue blood flow and oxygen assessment. The company specializes in laser Doppler and laser speckle imaging technologies for pre-clinical, clinical, and research applications. Their product portfolio serves diverse markets including stroke research (MCAO models), hind limb ischemia (HLI) studies, microcirculation assessment, cerebral blood flow monitoring, and muscle oxygenation evaluation. Applications span neuroscience, cardiovascular physiology, diabetes research, thermoregulatory studies, and extreme environment physiology. Moor operates globally through offices in the UK, Germany, and the USA, complemented by approximately 50 regional distributors. The company is recognized for robust, reliable equipment with comprehensive after-sales support and demonstrates strong presence at major scientific conferences including the Society for Neuroscience and World Congress of Microcirculation.

Asuragen is a molecular diagnostics company specializing in genetic carrier screening and precision oncology testing. Founded in 2006 and acquired by Bio-Techne Corporation in 2021, the company develops advanced diagnostic solutions utilizing proprietary chemistries and miRNA-based technologies. Their product portfolio includes genetic testing kits for inherited disorders (Fragile X, CFTR, SMN1/2, HTT), precision oncology solutions for chronic myeloid leukemia (CML) and solid tumor monitoring, custom molecular quality controls, and armored RNA controls. The AmplideX product line encompasses PCR/CE-based assays optimized for clinical laboratories. Asuragen operates a GMP-compliant manufacturing facility and CLIA-certified laboratory, serving clinical diagnostics and research applications across oncology, genetic disorders, and carrier screening markets. The company maintains strategic partnerships and distributes products across North America and EMEA regions.

Alveo Technologies is a molecular diagnostics company specializing in decentralized, point-of-need pathogen detection platforms. The company's flagship be.well platform integrates sample preparation, nucleic acid amplification, and real-time electrical sensing detection into a palm-sized, portable analyzer delivering results in under one hour. Applications span acute respiratory infections (COVID-19, influenza), avian influenza in poultry, plant pathogens in agriculture, and environmental/wastewater surveillance. The platform is cloud-connected, smartphone-guided, and designed for use by non-specialized personnel in field settings. Alveo serves livestock, food & beverage, companion animal, and public health sectors, with partnerships including Royal GD (Netherlands) for veterinary diagnostics and deployment across Egypt for nationwide avian flu surveillance.

LaCAR MDx Technologies is a Belgian biotechnology company specializing in CE-IVD certified diagnostic kits and integrated solutions for genetic testing. The company develops and manufactures comprehensive laboratory solutions covering newborn screening (early detection of congenital and metabolic diseases), pharmacogenetics (treatment optimization based on genetic profiles), and genetic predisposition/disorder diagnostics. LaCAR MDx offers an end-to-end platform combining diagnostic kits, qPCR and LAMP-based instruments, and interpretation software (GeneFoxCub). ISO 13485 compliant, locally produced in Liège, the company serves over 250 clients across 50+ countries, emphasizing quality, automation, and responsive customer support for laboratory workflows from sample processing to result analysis.

Everly Health (formerly Everlywell) is a consumer health testing company based in Austin, Texas, offering at-home lab testing kits that enable individuals to conduct accessible, affordable health diagnostics without requiring a doctor's visit or prescription. The company operates a network of validated tests covering food sensitivity, allergy, hormone, STD, thyroid, cholesterol, and wellness biomarkers—over 30 offerings in total. Customers perform self-collection of samples at home, mail them to certified partner laboratories, and receive digital results within days. Following its 2017 Shark Tank appearance, Everlywell expanded to over 2,000 retail locations including Target and CVS. In 2021, the company consolidated operations by acquiring PWNHealth and Home Access Health to form Everly Health, broadening its service portfolio to include telehealth consultations via a national clinician network. The platform emphasizes proactive, preventative health management with easy-to-understand results and actionable health insights tailored to individual biomarkers.

DiaPharma Group, Inc. manufactures specialty research and clinical assay kits, reagents, and hemostasis analyzers for bleeding/clotting disorders, thrombosis, liver disease, drug-induced organ injury, and anti-cancer drug development. Founded in 1997, the company employs scientists with expertise in hemostasis, coagulation testing, platelet function analysis, fibrosis biomarkers, and NETosis research. DiaPharma offers chromogenic substrates, ADAMTS13 assays, Factor X testing, and mechanistic biomarkers for MASH, alcoholic liver disease (ALD), and drug-induced liver injury (DILI). The company provides personalized scientific support and customer service to clinical laboratories, research institutions, and pharmaceutical development teams.

Medix Corporation is a comprehensive medical supply distributor based in Thousand Oaks, California, serving laboratories, healthcare facilities, and government agencies. The company operates an extensive catalog spanning laboratory safety equipment, clinical laboratory consumables, microbiology supplies, and physician-grade medical supplies. Product lines include microscopes, pipettes, culture media, sterilization equipment, PPE (gloves, masks, respirators), gauze and dressings, syringes and needles, surgical instruments (scalpels, forceps, sutures), phlebotomy supplies, and laboratory chemicals. Medix serves clinical laboratories, hospitals, educational institutions, and government entities at federal, state, and local levels. The company offers online ordering, telephone, fax, and email ordering options with monthly specials and a customer service team dedicated to order accuracy and satisfaction.

RODIMEDI & Associates Inc. is a medical product distributor serving Puerto Rico, the US Virgin Islands, and Continental USA for over 30 years. The company supplies laboratory and hospital essentials including rapid diagnostic tests (COVID, Flu, RSV), blood collection supplies, personal protective equipment, specimen containers, needles and holders, cleaning and sanitizing products, and sharps containers. RODIMEDI operates as a CLIA-waived diagnostic provider and serves +500 active clients with +3,500 fulfilled orders annually, benefiting 2M+ patients yearly. The company manufactures proprietary brands including RedTunica (rapid diagnostics and collection supplies), Bodyform (women's personal care), and SEDiREDi (ESR systems), while also representing major manufacturers including InSTI, LifeSign, AccessBio, Wondfo, Biochem, Puritan, and others.

Corgenix Medical Corporation is a CAP/CLIA-accredited in vitro diagnostics (IVD) company founded in 1990 and based in Broomfield, Colorado. The company specializes in developing, manufacturing, and commercializing diagnostic kits and operates as a Contract Development and Manufacturing Organization (CDMO) serving biotech companies, pharmaceutical firms, cancer centers, and academic laboratories. Corgenix offers over 50 diagnostic tests targeting immunology disorders, cardiovascular and vascular diseases, bone and joint disorders, and viral hemorrhagic diseases. Notable offerings include non-blood-based aspirin effect testing and multiple myeloma monitoring tools. The company provides comprehensive services across the IVD lifecycle: biomarker discovery, assay development, analytical and clinical validation, regulatory submissions, GMP manufacturing, quality control, and commercialization support. With an onsite CAP/CLIA laboratory, Corgenix supports clinical studies, trial management, physician-ordered patient testing, and research initiatives while maintaining strict regulatory compliance and GCP/GLP standards.

Pentapharm AG is a Swiss manufacturer of active pharmaceutical ingredients (APIs), diagnostic reagents, and biochemical products founded in 1948 and headquartered in Aesch, Basel-Landschaft. Specializing in hemostasis, coagulation, and anticoagulation therapies, the company supplies the pharmaceutical and diagnostic industries with naturally derived APIs including Aprotinin, Batroxobin, and Haemocoagulase—all supported by Drug Master Files (DMFs) and CEP certificates. The company manufactures standardized biochemicals for research, quality control, and analytical applications; highly purified snake venom enzymes for plasma coagulation and fibrinolysis modulation; proteinase inhibitors for proteolytic control; and synthetic peptide substrates (chromogenic, fluorogenic, amperogenic) for diagnostic assay development and proteinase activity monitoring. Pentapharm also develops and produces in-vitro diagnostic (IVD) reagent kits and research-use-only (RUO) kits for coagulation and fibrinolysis analysis. All manufacturing operates under GMP standards with strong emphasis on regulatory compliance, quality assurance, and accelerated time-to-market for partner pharmaceutical and diagnostics companies.

Medical & Biological Laboratories Co., Ltd. (MBL) is Japan's leading research reagent and diagnostic supplier, established in 1969. As the nation's first antibody manufacturer, MBL specializes in high-quality research reagents, diagnostic reagents, and customized companion diagnostics for clinical laboratories, hospitals, and life science researchers globally. The company operates R&D facilities in Nagano and Ibaraki, with a distribution center in Chiba. MBL's extensive product portfolio encompasses monoclonal and polyclonal antibodies, MHC tetramers, organoid growth factors, epitope tags, cell culture reagents, flow cytometry reagents, magnetic particles, latex particles, and specialized research tools across immunology, cancer research, autoimmune disease diagnostics, epigenetics, neuroscience, and drug discovery. Key branded product lines include CycLex, CircuLex, CoralHue™, HRP-DirecT, RiboCluster Profiler™, IMMUTEX™, and Magnosphere™. MBL supplies both research-use-only (RUO) and in vitro diagnostic (IVD) products to academic institutions and clinical diagnostics centers worldwide.

Cambridge Cognition is a neuroscience technology company specializing in digital cognitive assessment platforms for central nervous system (CNS) clinical trials. With over 30 years of scientific validation and expertise, the company provides an end-to-end solution for pharmaceutical companies, contract research organizations, and academic institutions. Core offerings include CANTAB® touchscreen cognitive assessments, voice analysis for verbal cognitive testing, electronic questionnaires and scales, high-frequency testing capabilities, decentralized clinical trial management, and automated quality assurance for clinical scales. The platform supports remote patient monitoring and decentralized trial recruitment, enabling drug developers to conduct cognitive efficacy and safety assessments in clinical or home settings. Cambridge Cognition's assessments have been validated across 3,000+ peer-reviewed publications and 250+ disease indications, including Alzheimer's disease, ADHD, depression, Parkinson's disease, multiple sclerosis, and schizophrenia. The company serves as a trusted partner for detecting subtle cognitive changes and generating objective biomarkers to accelerate brain health research and drug development timelines.

Lonza is a Swiss multinational contract development and manufacturing organization (CDMO) founded in 1897, headquartered in Basel. The company operates 30+ development and manufacturing sites globally and employs approximately 20,000 colleagues across five continents. As the pioneer and world leader in the CDMO industry, Lonza specializes in biopharmaceutical manufacturing and offers integrated services across biologics development, mammalian cell culture systems, small molecules and highly potent active pharmaceutical ingredients (HPAPIs), bioconjugates, cell and gene therapies (CGT), advanced mRNA technologies, and specialized modalities. The company also manufactures pharmaceutical capsules and health ingredients for nutraceutical applications. Lonza provides end-to-end support from drug development through manufacturing and commercialization, serving major pharmaceutical and biotechnology customers globally. Notable partnerships include production collaboration with Moderna for COVID-19 vaccine manufacturing.

Lighthouse Lab Services is a Charlotte, North Carolina–based full-service medical laboratory consulting, recruiting, and operational solutions firm. Founded in 2003 and expanded through strategic acquisitions including Elite Diagnostics (2019), the company serves as a comprehensive partner for laboratory startup, compliance, staffing, and operations management. Services include CLIA/COLA/CAP certification and compliance support, laboratory startup and design, specialized recruiting and medical director placement (serving 200+ CLIA-accredited labs nationwide), equipment procurement and instrument servicing with OEM components and FDA-certified engineers, test validation, quality management, revenue cycle management and payer contracting, LIS software solutions (Beacon LIS platform), and specialized molecular and toxicology laboratory solutions. The company specializes in infectious disease, pathology, molecular diagnostics, toxicology, and cytology. With a team of 150+ experts managing and supporting hundreds of laboratories across the United States, Lighthouse positions itself as the nation's largest dedicated medical laboratory consulting and recruiting firm.

Epsilon Elektronik Sanayi ve Ticaret A.Ş. is a Turkish medical equipment distributor and solution provider established in 1993, based in Istanbul with over 30 years of specialization in nuclear medicine, radiation oncology, and medical imaging. The company holds ISO 13485:2016 and ISO 9001:2015 certifications and serves as the authorized distributor for leading international manufacturers including IBA Dosimetry, Mirion/Capintec, QFix, Modus QA, CLERAD, and LabLogic. Epsilon offers comprehensive services including turnkey nuclear medicine center project management, technical support, calibration, and quality control testing for dose calibrators and gamma cameras. The company develops proprietary innovations such as Ge-68 calibration sources, I-125 tumor localization seed sources, and Co-57 flood sources for SPECT/PET imaging systems. Additional product portfolio includes radiation protection equipment, lead shielding products, water phantoms, patient positioning and immobilization devices, dosimetry systems, and decontamination solutions. Epsilon engages in international trade, exporting to the Netherlands, China, and importing from the United States and Russia, positioning itself as a comprehensive B2B solution partner for hospitals, imaging centers, and radiation therapy facilities across Europe and Asia.

Ontogen Medtech is a full-service medical device development and contract manufacturing partner based in Lisle, Illinois. Founded in 2021, the company specializes in end-to-end product realization for Class I, II, and III medical devices and in-vitro diagnostics across multiple therapeutic areas including orthopedics, cardiovascular, neurosurgery, women's health, pediatrics, and airway management. Services encompass strategic product design, engineering, prototyping, verification and validation testing, regulatory management (FDA compliance, 510(k) support), design history file documentation, and contract manufacturing from pilot builds to large-scale production. Ontogen operates a state-of-the-art facility with Class 7 cleanroom capabilities and sterilization coordination expertise. The team brings over 45 years of combined experience in sensor-driven smart devices, minimally invasive catheters, drug preparation and infusion systems, and class III implants. The company serves entrepreneurs, startups, and established medical device organizations, with a track record supporting clients through SBIR grants, pitch competitions, patent filings, and FDA clearances.

Trivitron Healthcare is a Chennai-based private medical technology company established in 1997, operating across 180+ countries with 15 USFDA- and CE-certified manufacturing facilities. The company specializes in integrated healthcare solutions spanning medical imaging, in-vitro diagnostics (IVD), newborn screening, radiation protection, critical care equipment, renal care solutions, and operating room systems. Trivitron delivers comprehensive turnkey healthcare solutions including facility design, equipment procurement, installation, and ongoing maintenance support. The company operates modern laboratory platforms for high-throughput automated diagnostics, portable screening systems for early disease detection in resource-limited settings, patient monitoring and ventilation systems for ICU environments, and AI-enhanced imaging analytics. With over 100,000 customers including hospitals, clinics, and laboratories globally, Trivitron focuses on making quality healthcare accessible and affordable in underserved regions, particularly across Africa and developing economies.

Mediso Medical Imaging Systems is a Budapest-based leader in nuclear and molecular imaging since 1990, developing, manufacturing, and servicing advanced imaging systems for both clinical patient care and preclinical research. The company operates over 1,400 clinical and 350 preclinical systems across more than 100 countries. The clinical product platform, AnyScan®, delivers multi-level nuclear medicine imaging systems including gamma cameras, SPECT, SPECT/CT, and integrated SPECT/CT/PET configurations with unified graphical user interface and multimodality image reconstruction software. Preclinical offerings include the nanoScan® family, featuring high-end small-animal imaging with PET, SPECT, CT, and cryogen-free MRI (3T, 7T) capabilities. Mediso provides FDA-approved InterView™ multimodality image processing and reporting software, clinical training services, and comprehensive support for hospitals, research institutions, and clinics worldwide.

PreOmics GmbH is a German proteomics company specializing in sample preparation solutions, automation platforms, and liquid chromatography tools for mass spectrometry-based protein and peptide analysis. Founded in 2016, the company provides an integrated ecosystem of consumables (iST kits, BeatBox® homogenizers, ENRICH enrichment technologies), automation platforms (APP96™ for high-throughput processing, PreON® for mid-throughput workflows), high-performance LC columns (PepSep®), and data visualization software (ProteoVision™). PreOmics solutions address applications in drug discovery, biomarker analysis, plasma proteomics, and high-throughput proteomics, serving pharmaceutical, biotech, academic, and clinical research laboratories globally. The company also offers CRO services and third-party automation integration with Agilent, Beckman, Hamilton, Opentrons, and Tecan platforms.

PAN-Biotech GmbH is a leading German manufacturer of high-quality cell culture products and biopharmaceutical reagents. Founded in 1988 and headquartered in Aidenbach, Bavaria, the company specializes in media, sera, serum-free systems, biologicals, and reagents for research, biotechnology, and pharmaceutical applications. Certified under GMP, ISO 9001:2015, and FDA-registered, PAN-Biotech delivers "Made in Germany" solutions tailored for cell and gene therapy, vaccine production, mRNA technology, and antibody production. The product portfolio encompasses classical and serum-free media, high-quality sera, specialized reagents for DNA/RNA pharmaceuticals, buffer solutions, and advanced formats for scalable upstream and downstream bioprocessing. The company serves biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), and research institutions globally, supporting the development of modern therapeutics with compliant, efficient, and scientifically rigorous products.

CTCELLS is a precision oncology company specializing in advanced liquid biopsy diagnostics and innovative immunotherapy development. The company leverages proprietary Circulating Tumor Cell (CTC) isolation technology powered by automated microfluidic systems to enable comprehensive analysis of all CTC types. CTCELLS offers two integrated platforms: (1) CTCeptor, a diagnostic platform for total CTC isolation and characterization, complemented by HyPICC (Hydrogel Pellicle for Lossless Immunocytochemistry) technology achieving >97% cell retention for downstream analysis; and (2) therapeutic development programs including RACE (Receptor Antibody Conjugated Engager) bispecific antibodies and Membrane Bound Protein (MBP)-enhanced natural killer cell therapies. The company's integrated diagnostics-to-therapeutics model enables patient-tailored cancer treatment matching individual tumor characteristics with optimized therapeutic approaches.

UTAK Laboratories Inc. is a family-owned manufacturer specializing in high-quality quality control (QC) materials for clinical, forensic, and reference testing laboratories. Founded in 1973 by toxicology chemist Larry Plutchak and headquartered in Valencia, California, UTAK has served clients in 29 countries for over 50 years. The company manufactures both stock QC materials and custom-designed controls using 100% real human matrices including urine, blood, serum, oral fluid, and hair. UTAK offers products for therapeutic drug monitoring, toxicology, drugs of abuse testing, and specialized analyte panels. The company positions itself as an independent QC partner that eliminates the need for labs to establish internal manufacturing, reducing compliance risk, overhead, and labor burden while providing audit-ready documentation, certificates of analysis, and stability data. Rapid turnaround (approximately 15 days for custom formulations) and conversion of successful formulations to stocked inventory support recurring supply relationships. UTAK serves university hospitals, medical centers, forensic labs, and reference laboratories, including tier-one clients such as Quest Diagnostics.

C.G. Laboratories, Inc. is a multi-service medical device contract manufacturer and testing laboratory founded in 1983 and headquartered in Granbury, Texas. The company specializes in medical device decontamination, contract packaging, laboratory testing, sterilization validation, and environmental monitoring. With over 40 years of operational experience and 19,000 square feet across two facilities, C.G. Labs serves the medical device, tissue, and dental industries. The company is FDA-registered and ISO 13485:2016 and MDSAP accredited. Core competencies include microbiological analysis, regulatory testing, reusable medical device validation, water testing, air microbial monitoring, and IFU development. C.G. Labs offers customizable decontamination and sterilization services with turnaround times exceeding 72-hour performance objectives, end-to-end contract packaging (sterile and non-sterile), and comprehensive validation support including process validation and equipment qualification. The laboratory team collectively has over 90 years of medical device industry experience.

Hysen Inc. (Hysen Biotech) is a specialized manufacturer and distributor of innovative drug screening and diagnostic devices. With over a decade of commitment to the diagnostics community, the company partners directly with distributors in biotechnology and medical sectors, guiding diagnostic products from concept through commercialization. The company specializes in FDA-cleared multi-panel drug testing solutions, including urine test cups, dip cards, saliva tests, and cassettes designed for rapid point-of-care drug screening. Their product portfolio includes lateral flow immunoassay platforms and cup reader technologies for instant result interpretation. Hysen serves occupational health, forensic, clinical, and compliance testing markets with CLIA and 510(k)-cleared devices.

AcroCyte Therapeutics Inc. develops the R³CE® (Rapid, Reproducible, Rare Cell 3D Expansion) platform—an FDA-designated Class I, scaffold-free system that rapidly expands minimal patient specimens including circulating tumor cells, needle biopsies, and frozen tissues into functional 3D organoids within days. The company offers R³CE® culture plates and specialized media for research and clinical applications, alongside the Onco-REAL™ clinical diagnostic service providing comprehensive functional analysis from liquid biopsies to support oncology treatment decisions. AcroCyte's technology platform enables drug developers to accelerate preclinical screening, clinicians to deliver personalized ex vivo drug sensitivity testing, and researchers to create customized 3D models that replicate physiological conditions. The platform eliminates reliance on traditional cell lines and animal models, addressing key limitations in reproducibility, speed, and sample efficiency for precision medicine applications across oncology, regenerative medicine, and drug discovery.

Lynn Medical is a family-owned specialty medical distributor based in Wixom, Michigan, with over 56 years of proven expertise serving the healthcare market. Founded in 1966, the company distributes diagnostic supplies and equipment with a focus on cardiology and imaging procedures. Lynn Medical serves more than 2,000 healthcare specialty practices, physician offices, clinics, hospitals, and laboratories nationwide. The company maintains partnerships with over 100 manufacturers and stocks more than 150,000 products, including cardiac catheterization equipment, ECG systems, patient monitoring devices, ultrasound supplies, electrodes, IV and infusion products, PPE, disinfection products, and point-of-care assays. With a team of 30+ clinical professionals offering technical expertise and consultation, Lynn Medical provides comprehensive solutions designed to improve patient management and reduce healthcare costs, backed by competitive pricing, reliable inventory management, and responsive customer service.

Esco Lifesciences Group is a world-leading manufacturer of laboratory and biopharma equipment, biological safety cabinets, and IVF medical devices, headquartered in Singapore since 1978. The company serves over 100 countries with a diversified portfolio spanning clinical diagnostics, pharmaceutical manufacturing, bioprocessing, and assisted reproductive technology (ART). Core product lines include CO₂ incubators (CelCulture® Touch series), temperature-controlled shakers (OrbiCult™), biosafety cabinets, fume hoods (Frontier Duo series), PCR cabinets, ultra-low freezers, and cryogenic storage systems. Esco also operates Esco Aster, a CDMO providing contract manufacturing and process development services across upstream/downstream bioprocessing, formulation, and filling. The company employs over 1,700 staff across multiple R&D and manufacturing sites, offering comprehensive support including installation, certification, training, maintenance, and decommissioning services. Applications span pharmaceutical QC, clinical diagnostics, food microbiology, cell therapy, gene therapy, medical device assembly, and biocontainment for BSL-3/4 research.

Medi-Dose, Inc. is a pharmaceutical packaging and hospital supply distributor specializing in unit-dose packaging systems, liquid packaging solutions, and specialized medical consumables. Based in Ivyland, Pennsylvania, the company manufactures and distributes a broad range of products for pharmacy operations, nursing units, compounding centers, operating rooms, and specialized clinical settings including ophthalmic, maternity, and laboratory applications. Core offerings include the proprietary Medi-Dose System for unit-dose packaging, Steri-Dropper sterile dropper bottles, TampAlerT tamper-evident liquid packaging, ENFit-compliant products for enteral feeding, identification bands, safety-labeled bags for hazardous drugs (USP <800> compliant), cleanroom supplies, compounding equipment, and pharmacy auxiliary labeling systems. The company also provides MILT 4 pharmacy management software and serves hospitals, healthcare systems, and long-term care facilities with both branded and custom solutions for medication safety, infection control, and operational efficiency.

Virchow Biotech Private Limited (VBPL) is an ISO 13485:2016 and WHO-GMP certified biopharmaceutical manufacturer established in 2001 in Hyderabad, India. With over 24 years of operational excellence, VBPL specializes in developing and manufacturing high-quality biogenerics, recombinant therapeutics, active pharmaceutical ingredients (APIs), and medical devices. The company is recognized as the first to commercialize biogenic formulations including Recombinant Platelet Derived Growth Factor (rhPDGF) for wound healing and Recombinant PTH for osteoporosis treatment. Additional key products include Pegylated Interferon and Rasburicase. VBPL operates advanced fermentation and recombinant biotech production facilities, offering contract research, manufacturing, co-development, and biopharmaceutical research services. With an annual turnover exceeding $1 billion and a workforce of over 5,000 professionals, the company maintains a global presence across 100+ countries with offices in the USA.

FUJIFILM Healthcare Americas Corporation is a leading provider of diagnostic imaging, enterprise imaging, endoscopic imaging, surgical imaging, and in vitro diagnostics solutions. With nearly 90 years of medical imaging heritage since 1936, the company delivers comprehensive healthcare technology portfolios spanning prevention, diagnosis, and treatment. Key offerings include the Synapse® Enterprise Imaging platform for clinical workflow optimization, advanced diagnostic imaging systems, endoscopy device and imaging technology portfolios, surgical imaging solutions, and serum biomarker assays for liver cancer screening. The company serves healthcare organizations across the care continuum, providing integrated solutions that support clinicians, administrators, and patients through tailored user experiences and clinical decision support capabilities.

Premier Medical USA Corporation is a world leader in developing and manufacturing rapid diagnostic tests for infectious diseases. Based in Somerset, New Jersey, the company leverages more than 30 years of experience in manufacturing and distributing diagnostic solutions globally. Premier Medical specializes in lateral flow technology and emerging diagnostic platforms, with a global network of scientists and researchers supporting in-house development. The company collaborates with prestigious organizations, agencies, and universities to develop high-quality, affordable diagnostic tools for infectious disease detection and distribution worldwide.

RPI Biosolutions is a B2B supplier of biochemicals, growth media, molecular biology reagents, and laboratory equipment for research institutions and clinical laboratories. The company provides amino acids, agarose, buffers (including PBS solutions), electrophoresis reagents, antibiotics, enzymes (IPTG), and microbial culture media (LB agar, yeast extract, terrific broth). Product offerings also include laboratory instruments such as centrifuges, precision balances, and sample handling supplies (tubes, racks, labels, microscope slides). RPI is committed to sustainability practices and offers special programs including discounts for new or relocating laboratories. The company serves academic research, biotechnology, pharmaceutical, and diagnostic sectors.

Princeton BioMeditech Corporation (PBM) is a world leader in rapid, point-of-care diagnostic products. The company manufactures and distributes an extensive portfolio of over 70 different one-step rapid diagnostic tests utilizing patented immunoassay technologies. PBM serves both consumer in-home and professional on-site/point-of-care markets with FDA-cleared and ISO 13485:2016 certified products. Product lines include rapid antigen detection tests for COVID-19/Flu, cardiac markers, infectious disease diagnostics, fertility testing, drugs of abuse screening, tumor markers, and food/environmental pathogen detection. The company offers OEM services, point-of-care analyzer systems, research and development capabilities, and comprehensive product support. Based in Princeton, New Jersey, PBM maintains USA manufacturing operations and serves healthcare providers, clinical laboratories, and consumers globally.

Zymo Research Corp is a biotechnology company founded in 1994, specializing in molecular biology tools and services. Based in Irvine, California, the company focuses on DNA and RNA purification, epigenetics, microbiomics, and next-generation sequencing (NGS). With approximately 116 employees and annual revenue of $22.8 million, Zymo Research has established a global presence with six international facilities and a wide distribution network. The company emphasizes simplicity in science through its philosophy of 'The Beauty of Science is to Make Things Simple.' Zymo Research prioritizes customer feedback to develop innovative technologies that enhance scientific workflows. Their product offerings include sample preservation solutions (DNA/RNA Shield), comprehensive sequencing and analysis services, advanced purification technologies (Direct-zol, ZymoPURE, Quick-DNA/RNA kits), epigenetics tools (EZ DNA Methylation, bisulfite sequencing), and microbiome standards. Zymo serves academia, healthcare, and industry globally, collaborating with institutions to support scientific research and innovation.

PHASE Diagnostics is a diagnostics technology company specializing in rapid and at-home testing solutions powered by proprietary PHASIFY™ technology. The company develops innovative diagnostic offerings focused on early detection and prevention, with particular emphasis on cancer and infectious disease screening. PHASE offers three primary product lines: INDICAID rapid tests for point-of-care use, INDICAID lab at-home laboratory tests, and PHASE lab medical testing services. The PHASIFY™ technology platform enables rapid detection of target molecules, supporting urine-based and other non-invasive screening methods including HPV cervical cancer screening and respiratory pathogen detection. The company holds FDA CLIA waiver status and conducts clinical studies to validate diagnostic accuracy. PHASE positions itself at the intersection of preventive healthcare and diagnostic innovation, targeting both consumer self-testing and clinical laboratory markets.

Hamilton Company is a global manufacturer of precision liquid handling equipment and process analytics solutions for life sciences research and bioprocessing. Founded in the late 1940s and headquartered in Reno, Nevada, with European operations in Bonaduz, Switzerland, Hamilton specializes in microliter syringes, automated liquid handling systems, sample storage solutions, and in-line process monitoring sensors. The company serves pharmaceutical, biotechnology, genomics, cell therapy, and analytical chemistry sectors with products ranging from hand-fitted manual syringes to fully integrated robotic automation platforms. Hamilton's solutions support critical workflows including NGS library preparation, cell culture, bioprocess monitoring, compound handling, and high-throughput screening. The company emphasizes application-specific customization, field service support, and training programs to enable seamless workflow integration across benchtop and production-scale operations.

Eagle Biosciences, Inc. is a specialized life sciences reagent supplier focusing on immunological and molecular biology products. The company specializes in ELISA assays, MHC (Major Histocompatibility Complex) reagents, and loadable MHC tetramers and monomers for research applications. Eagle Biosciences offers a boutique approach to product sourcing, providing customized solutions including host cell protein detection assays, HLA-peptide complexes, and MHC class I and II reagents for immunology research. The company maintains an extensive catalog of pre-configured peptide-MHC products and offers custom product research and sourcing services for laboratory and clinical research institutions.

MarketLab is a healthcare products distributor founded in 1994 that specializes in low-to-mid volume specialty items and hard-to-find solutions for healthcare professionals. The company serves clinical laboratories, anesthesia, operating rooms, radiology, MRI, ultrasound, home healthcare, pharmacy, and sterile processing departments across U.S. health systems, integrated delivery networks, and government agencies. Product offerings span phlebotomy supplies, patient positioning and comfort items, safety equipment, infection control and PPE dispensers (Bowman brand), medical carts and furniture (Insight brand), tube caps and racks, airway management, eye protection, and medical bags. MarketLab operates nine trusted brands and emphasizes quality, competitive pricing, and direct feedback from healthcare professionals to develop practical solutions that improve workflow and reduce procurement friction.

Heathrow Scientific is a global manufacturer of laboratory supplies and equipment founded in 1996 and headquartered in Vernon Hills, Illinois. The company has expanded from two initial products to a diversified portfolio of over 800 items serving education, healthcare, industrial, and research sectors. Heathrow Scientific specializes in laboratory storage solutions (interlocking racks, slide boxes, tube carriers), sample handling equipment (centrifuges, pipette fillers), cooling containers, general glassware, safety products, and biohazard containment systems. The company employs laboratory professionals within its R&D team to develop ergonomic, user-focused solutions that enhance lab efficiency and workflow. With independent audits confirming 99.7% equipment reliability and 99.9% supply reliability, Heathrow Scientific emphasizes quality control and product innovation for clinical and research laboratory environments.

Anhui Deepblue Medical Technology Co., Ltd. is a leading in vitro diagnostic (IVD) reagent manufacturer established in 2010 and headquartered in Hefei High-Tech Zone, Anhui, China. Specializing in R&D, manufacturing, and global marketing of rapid diagnostic test kits and biological raw materials, the company serves gynecological, family planning, and digestive medicine markets. Core product lines include HCG pregnancy test strips, LH ovulation test strips, fecal occult blood tests, IGFBP-1 PROM test kits, bacterial vaginosis tests, PCT test kits, infectious disease rapid tests, respiratory disease tests, tumor marker tests, drug-of-abuse tests, and virus sampling tubes (VTM). The company maintains ISO 13485:2016 and MDSAP certifications, with CE0123, CE1434, and UK MHRA approvals. Products are distributed across nearly 100 countries including Europe, North America, South America, the Middle East, and Southeast Asia. Deepblue Medical offers OEM/ODM services, advanced automation production capabilities, and comprehensive after-sales support for hospital, clinical laboratory, and point-of-care diagnostic applications.